Lumakras is a prescription oral tablet used to treat certain types of non-small cell lung cancer in adults. Learn about its side effects, dosage, uses, and more.

Approval of Lumakras, which will be given as a 960 mg dose (eight 120 mg tablets taken once daily), came more than two months early. The target date for a decision was August 16.

But while the drug has helped keep him alive, its side effects have narrowed the confines of his life. “My appetite has been minimal. I’m very weak. I walk my dogs and get around a bit, but I ...